… as leading to death (53 erlotinib; 27 PBO). Only 5 of … Erlotinib combined with carboplatin
and paclitaxel chemotherapy did not confer a survival advantage over carboplatin and paclitaxel …

… Erlotinib with concurrent carboplatin and paclitaxel did not confer a survival advantage over
carboplatin and paclitaxel … Never smokers treated with erlotinib and chemotherapy seemed …

… of erlotinib in combination with paclitaxel and carboplatin on … pharmacokinetics of erlotinib,
paclitaxel, and carboplatin in … of erlotinib on the clearance of paclitaxel and carboplatin; (d) …

… erlotinib with carboplatin and paclitaxel 6). In this previous study, there was no evidence of
a pharmacokinetic interaction between paclitaxel and erlotinib, … during erlotinib treatment. …

… kinase inhibitor erlotinib in combination with first-line carboplatin-paclitaxel chemotherapy
in … We found no evidence that addition of erlotinib to carboplatin-paclitaxel improved the …

… use bevacizumab and erlotinib concurrently with paclitaxel and carboplatin in the … paclitaxel
and carboplatin. For patients felt to be benefiting from treatment, bevacizumab and erlotinib …

… kinase inhibitor (TKI) erlotinib is an effective treatment for … The efficacy of EGFR TKIs, including
erlotinib, is greatest in the … the role of adding erlotinib to first-line carboplatin and paclitaxel …

… of erlotinib followed by carboplatin and paclitaxel) be compared with carboplatin and paclitaxel
… In the TRIBUTE trial, 495 former or current smokers receiving carboplatin and paclitaxel …

… rate and safety profile of erlotinib HCl (erlotinib, Tarceva™, OSI-… Thirty-four patients received
150 mg erlotinib orally once daily … Erlotinib was generally well tolerated. The most frequent …

… to erlotinib was observed in the doxorubicin-resistant human breast cancer cell line MCF-7,
paclitaxel-… The IC 50 values of erlotinib in the resistant cell lines were 2- to 20-fold lower than …